Explore
Flex AV Registry
FLEX FIRST AV Registry 6-Month Data
NEW Registry Data presented at Charing Cross: Demonstrated procedural safety and meaningful outcomes in a real-world patient population with challenging lesions.
FLEX AV Registry 12-Month Results
Proven in real-world practice: Extending time with sustained efficacy in treating difficult lesions.
VentureMed Group, Inc. develops and markets innovative endovascular medical devices to solve unmet medical needs in the treatment of PAD and stenoses of AV fistulas and grafts.
VentureMed Group, Inc. is a member of Medical Alley